As the US healthcare sector continues to grapple with rising costs and dwindling resources, a growing concern has emerged over the influence of private equity firms on non-profit providers. A scathing report by the Private Equity Stakeholder Project (PESP) warns that partnerships between these investors and charitable organisations risk compromising patient care, exploiting financial benefits, and undermining the sector's core values.
The report highlights more than 500 joint ventures across America, spanning rural hospitals, major religious health systems, and hospice care. PESP Executive Director Jim Baker suggests this figure is likely a fraction of the total number, given the opaque nature of private equity ownership which often shrouds dealings in secrecy. Building on previous work by PESP, the report reveals 488 US hospitals – an astonishing 8.5% of all private hospitals – are now under private equity control, fuelling concerns about profit-driven priorities.
Over the past decade, private equity funds have poured over $1 trillion into debt-financed healthcare deals in the US, according to researchers at New York University. This trend has sparked intense scrutiny from lawmakers and academics who fear that short-term investment horizons and debt-fuelled acquisitions may erode patient care standards. Health policy expert Erin Fuse Brown of Brown University School of Public Health highlights the inherent conflict between a non-profit hospital's charitable mission and a for-profit investor group's drive for returns.
The regulatory framework governing these joint ventures has its roots in 1998 and 2004 IRS decisions, which allowed non-profits to maintain tax-exempt status provided they retained control over their mission. However, PESP argues that increased oversight is needed to prevent these partnerships from exploiting charitable status for financial gain.
While joint ventures can offer benefits to both partners, the report warns that those backed by private equity may still carry significant risks associated with private equity buyouts in healthcare – a phenomenon linked to an increase in serious medical errors, according to a major study published in JAMA. As lawmakers grapple with the implications of these findings, they must carefully weigh the potential benefits against the need for enhanced oversight and stronger protections for patient care.
The debate surrounding private equity's influence on healthcare highlights the delicate balance between profit-driven investment and charitable mission. As Britain watches this unfolding saga across the Atlantic, policymakers here may take note: how can we ensure our own non-profit healthcare providers remain true to their founding principles in an era of increasing market pressure?